Hound Partners, LLC Iterum Therapeutics PLC Transaction History

Hound Partners, LLC

  • $410 Million
  • Q2 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 14, 2019
SELL
$5.01 - $7.9 $97,695 - $154,050
-19,500 Closed
0 $0
Q3 2018

Nov 14, 2018
BUY
$6.24 - $10.4 $121,680 - $202,800
19,500 New
19,500 $129,000

Others Institutions Holding ITRM

# of Institutions
1
Shares Held
66
Call Options Held
0
Put Options Held
0
View Full List

About Iterum Therapeutics plc

ITRM Quotes by TradingView
  • Ticker ITRM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 12,233,400
  • Market Cap $15.9M
  • Description
  • Iterum Therapeutics plc, a clinical-stage pharmaceutical company, engages in developing and commercializing anti-infectives in Ireland, Bermuda, and the United States. It is developing sulopenem, a novel anti-infective compound with oral and IV formulations that is in Phase III clinical trials for the treatment of uncomplicated urinary tract inf...
More about ITRM
Track This Portfolio

Track Hound Partners, LLC Portfolio

Follow Hound Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hound Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hound Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email